| RS1553369826 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1553370260 |
MYCN
|
Health Risk |
Pathogenic |
Feingold syndrome type 1, Feingold syndrome type 1 |
| RS1553370287 |
MSH2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1553370310 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS1553370324 |
MSH2
|
Health Risk |
Pathogenic |
Malignant tumor of breast, Malignant tumor of breast |
| RS1553370345 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1553370366 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1553370371 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS1553370381 |
MSH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS1553370386 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1553370397 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1553370404 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1553370431 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1553370435 |
MSH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1553370437 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS1553370443 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1553370453 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1553370464 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1553370486 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1553370518 |
MYCN
|
Health Risk |
Pathogenic |
— |
| RS1553370869 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1553370884 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1553370905 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1553370918 |
MYCN
|
Health Risk |
Pathogenic |
Feingold syndrome type 1, Feingold syndrome type 1 |
| RS1553370963 |
MYCN
|
Health Risk |
Pathogenic |
Feingold syndrome type 1, Feingold syndrome type 1 |
| RS1553370992 |
MYCN
|
Health Risk |
Likely pathogenic |
— |
| RS1553371008 |
MYCN
|
Health Risk |
Likely pathogenic |
— |
| RS1553372935 |
ABCG5
|
Health Risk |
Pathogenic |
— |
| RS1553373926 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiovascular phenotype |
| RS1553375174 |
SLC1A4
|
Health Risk |
Pathogenic |
Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome, Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome |
| RS1553375267 |
ABCG8
|
Health Risk |
Likely pathogenic |
— |
| RS1553375366 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1553376538 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1553376558 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1553376691 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1553377740 |
DYSF
|
Health Risk |
Pathogenic |
— |
| RS1553377764 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1553380888 |
SFTPB
|
Health Risk |
Pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS1553381934 |
STAMBP
|
Health Risk |
Pathogenic |
— |
| RS1553381945 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1553382055 |
STAMBP
|
Health Risk |
Pathogenic |
Microcephaly-capillary malformation syndrome, Microcephaly-capillary malformation syndrome |
| RS1553382295 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1553382319 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1553382325 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1553382678 |
APOB
|
Health Risk |
Likely pathogenic |
Hypobetalipoproteinemia, Hypobetalipoproteinemia |
| RS1553383017 |
APOB
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, autosomal dominant |
| RS1553383144 |
DYSF
|
Health Risk |
Pathogenic |
— |
| RS1553383467 |
MPV17
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) |
| RS1553383473 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, autosomal dominant |
| RS1553383480 |
MPV17
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) |
| RS1553383898 |
APOB
|
Health Risk |
Pathogenic |
Familial hypobetalipoproteinemia, Familial hypobetalipoproteinemia |
| RS1553383931 |
APOB
|
Health Risk |
Pathogenic |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1553383983 |
ABCG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553384177 |
APOB
|
Health Risk |
Pathogenic |
Familial hypobetalipoproteinemia, Hypercholesterolemia |
| RS1553384441 |
APOB
|
Health Risk |
Pathogenic |
Familial hypobetalipoproteinemia, Familial hypobetalipoproteinemia |
| RS1553385404 |
APOB
|
Health Risk |
Pathogenic |
Familial hypobetalipoproteinemia, Hypercholesterolemia |
| RS1553385715 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1553386360 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1553387094 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1553387422 |
KCNK3
|
Health Risk |
Likely pathogenic |
Pulmonary hypertension, primary |
| RS1553387851 |
LHCGR
|
Health Risk |
Likely pathogenic |
Leydig cell agenesis, Leydig cell agenesis |
| RS1553388067 |
LRPPRC
|
Health Risk |
Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS1553389102 |
GFPT1
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 12, Congenital myasthenic syndrome 12 |
| RS1553390248 |
FIGLA
|
Health Risk |
Likely pathogenic |
Genetic non-acquired premature ovarian failure, Genetic non-acquired premature ovarian failure |
| RS1553390600 |
GFPT1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 12, Congenital myasthenic syndrome 12 |
| RS1553391303 |
LRPPRC
|
Health Risk |
Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS1553391515 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1553394254 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1553394366 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1553394475 |
SPAST
|
Health Risk |
Pathogenic |
— |
| RS1553394497 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1553394509 |
SPAST
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1553394603 |
SPAST
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1553394608 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1553394620 |
SPAST
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia, Hereditary spastic paraplegia 4 |
| RS1553394622 |
SPAST
|
Health Risk |
Likely pathogenic |
— |
| RS1553395132 |
MYT1L
|
Health Risk |
Likely pathogenic |
— |
| RS1553396088 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1553396091 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Alstrom syndrome |
| RS1553396092 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1553396098 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1553396232 |
LRPPRC
|
Health Risk |
Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS1553396238 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1553396293 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1553396296 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1553396458 |
ACTG2
|
Health Risk |
Pathogenic |
Visceral myopathy 1, ACTG2-related disorder |
| RS1553398334 |
LRPPRC
|
Health Risk |
Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS1553398842 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1553399472 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1553399476 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1553399493 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1553399498 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1553399962 |
ALMS1
|
Health Risk |
Likely pathogenic |
— |
| RS1553400002 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia |
| RS1553400013 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1553400259 |
POMC
|
Health Risk |
Pathogenic |
Obesity due to pro-opiomelanocortin deficiency, Obesity due to pro-opiomelanocortin deficiency |
| RS1553400391 |
LRPPRC
|
Health Risk |
Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS1553400437 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1553400438 |
NRXN1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1553400675 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |